EUVIMEDEUVIMED entdecken
Crossref

Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance

Kenneth J C Lim iD, Pietro Di Ciaccio iD, Mark N Polizzotto, Sam Milliken, Tara Cochrane iD, Zhong Goh, Briony Shaw, Evelyn Perry, Michael Gilbertson, William Kermode, Chan Y Cheah iD, Maya Latimer und 2 weitere

British Journal of Haematology · 2023

DOI: 10.1111/bjh.18704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Kenneth J C Lim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, St Vincent's Hospital Melbourne, Sydney, Melbourne, Australia. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, HIV Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiretroviral therapy (ART) has improved outcomes for human immunodeficiency virus‐associated non‐Hodgkin lymphoma (HIV‐NHL). This is an analysis of 44 patients with HIV with Burkitt lymphoma (HIV‐BL) and diffuse large B‐cell lymphoma (HIV‐DLBCL) treated in Australia over a 10‐year period (2009–2019) during the ART and rituximab era. At HIV‐NHL diagnosis, the majority of presenting patients had adequate CD4 counts and undetectable HIV viral load 0.2 ×10 9 /L 6 months after the end of treatment. Current Australian practice favours the treatment of HIV‐BL and HIV‐DLBCL similarly to the HIV‐negative population with the use of concurrent ART, achieving outcomes comparable to the HIV‐negative population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkitt LymphomaLymphoma, Large B-Cell, DiffuseHIV InfectionsHumansRituximabHIVAustraliaCyclophosphamideVincristineDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsRetrospective Studies

Stichwörter der Autor:innen

Burkitt lymphomaHIVantiretroviral therapydiffuse large B-cell lymphomanon-Hodgkin's lymphoma

Substanzen

RituximabCyclophosphamideVincristineDoxorubicin

Autor:innen und Institutionen

  • Department of Haematology, St Vincent's Hospital Melbourne, Sydney, Melbourne, Australia.
  • Department of Haematology, St Vincent's Hospital Sydney, Fitzroy, New South Wales, Australia.
  • College of Health and Medicine, Australian National University, Canberra, Australia.
  • University of New South Wales, Sydney, New South Wales, Australia.
  • Gold Coast University Hospital, Southport, Queensland, Australia.
  • Griffiths University, Nathan, Queensland, Australia.

ORCID-Profile: Kenneth J C Lim, Pietro Di Ciaccio, Tara Cochrane, Chan Y Cheah, Nada Hamad

Zitieren

APA

Lim, K. J. C., Di Ciaccio, P., Polizzotto, M. N., Milliken, S., Cochrane, T., Goh, Z., Shaw, B., Perry, E., Gilbertson, M., Kermode, W., Cheah, C. Y., Latimer, M., Hamad, N., & Ku, M. (2023). Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance. British Journal of Haematology. https://doi.org/10.1111/bjh.18704

Vancouver

Lim KJC, Di Ciaccio P, Polizzotto MN, Milliken S, Cochrane T, Goh Z, et al. Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance. British Journal of Haematology. 2023. doi:10.1111/bjh.18704

BibTeX
@article{Lim2023,
  author = {Lim, Kenneth J C and Di Ciaccio, Pietro and Polizzotto, Mark N and Milliken, Sam and Cochrane, Tara and Goh, Zhong and Shaw, Briony and Perry, Evelyn and Gilbertson, Michael and Kermode, William and Cheah, Chan Y and Latimer, Maya and Hamad, Nada and Ku, Matthew},
  title = {Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.18704}
}
Kostenlos starten →